(105 Results)
Filter
What are you looking for?
-
Category
-
Type
-
Year
-
Keywords
-
Author
Apply filters
Knowledge Hub
Collapse
-
Blister fluid analysis in allergic diseasesInternational research efforts significantly advanced our understanding of the local infla...
-
Conscious and rational use of antibiotics in allergic diseasesAntibiotics are one of the most frequently prescribed medicines; therefore antimicrobial r...
-
Systematic biobanking for precision medicine in asthma and allergic diseasesPrecision medicine is an emerging field gaining high interest due to the limitations of st...
-
Principles for targeting eicosanoids in the treatment of asthma and allergic diseasesEicosanoids are a family of fatty acid metabolites that includes prostaglandins, leukotrie...
-
Development of mHealth biomarkers for allergic diseases based on CSMS and machine learningBiologic biomarkers are not fully validated in allergic diseases. mHealth biomarkers repre...
-
Allergic diseases in adolescents and young people, towards better patient centred careThe EAACI Adolescent and Young Adult TF has published a guideline, two systematic reviews,...
-
EAACI Food Allergy GuidelinesWe are planning the following publications for 2022: 1. Systematic review of the literatur...
Show more Task Forces (5)Show Less-
-
The One Health approach for allergic diseases and asthmaAbstract The One Health approach is a collaborative and interdisciplinary strategy with f...
-
Dangerous liaisons: bacteria, antimicrobial therapies and allergic diseasesAbstract Microbiota composition and associated metabolic activities are essential for the...
-
Noninvasive and minimally invasive techniques for the diagnosis and management of allergic diseasesAbstract Allergic diseases of the (upper and lower) airways, the skin and the gastrointes...
-
Current perspective on eicosanoids in asthma and allergic diseases: EAACI Task Force consensus report, part IAbstract Eicosanoids are biologically active lipid mediators, comprising prostaglandins, ...
-
Emerging concepts and challenges in implementing the exposome paradigm in allergic diseases and asthma: a Practall documentAbstract Exposome research can improve the understanding of the mechanistic connections b...
-
Prioritizing research challenges and funding for allergy and asthma and the need for translational research - The European Strategic Forum on Allergic DiseasesAbstract The European Academy of Allergy and Clinical Immunology (EAACI) organized the fi...
-
Biologicals in atopic disease in pregnancy: An EAACI position paperAbstract Biologicals have transformed the management of severe disease phenotypes in asth...
-
A multi-disciplinary approach to the diagnosis and management of allergic disease: An EAACI Task ForceAbstract Background: Guidelines for management of patients with allergic conditions are...
-
Emerging roles of innate lymphoid cells in inflammatory diseases: Clinical implicationsAbstract Innate lymphoid cells (ILC) represent a group of lymphocytes that lack specific ...
-
Management of ocular allergyAbstract The treatment and management of ocular allergy (OA) remain a major concern for d...
-
Current practice of allergy diagnosis and the potential impact of regulation in EuropeAbstract In the European Union (EU), the regulatory framework regarding diagnostic allerg...
-
EAACI position paper on the clinical use of the bronchial allergen challenge: Unmet needs and research prioritiesAbstract Allergic asthma (AA) is a common asthma phenotype, and its diagnosis requires bo...
Show more Position Papers (10)Show Less-
-
Genetic Predisposition to allergic diseases is inversely associated to risk of COVID-19Allergic diseases such as allergic rhinitis (hay fever), atopic dermatitis (eczema) and as...
-
Position statement of expert panel of the Polish Allergology Society (PTA) on the management of patients with bronchial asthma and allergic diseases during the SARS-CoV-2 pandemicThe dynamically changing epidemiological situation related to SARS-CoV-2 infection poses c...
-
-
Epithelial cell barrier and allergic diseases
-
An update on prevention of allergic diseases
-
Novel insight into development of allergic diseases
-
Beyond first line therapies for recalcitrant allergic diseases: Asthma
-
Linking bovine milk components and their possible association with allergic diseases
-
Dupilumab suppresses serum total IgE levels across multiple atopic, allergic diseases
-
Lessons learned from immune tolerance approaches to target allergic diseases: an NIAD’s perspective
-
Introduction - why bacterial lysates in the treatment of allergic diseases? / Wprowadzenie – dlaczego lizaty bakteryjne w terapii schorzen alergicznych ?
-
Autoimmunity in atopic diseases
-
Differential diagnosis
-
How do allergens sensitize?
-
Nasal allergen challenge
-
Food allergy - the beginners guide
-
Food allergy: new allergens on the block
-
The dilemma of food allergy additives
-
Delabelling adults
-
Danger signs
-
Bronchial allergen challenge in research
-
Molecular allergology in daily clinical practice
-
Elderly asthma
-
Update on drug allergy
-
Electronic Health in Severe Asthma
-
Can group consultations work in allergy? Learning from rheumatology
-
Severe cutaneous allergic reactions: searching for the culprit drug
-
Over-the-counter allergy prevention weaning products
-
Psychological support to peanut allergic children and their families
-
Tree nut allergy: path from national to global data
-
Impaired olfaction: diagnostics and its role in diseases
-
AAAAI Practice Parameters
-
Asma e alergia em pandemia
-
Asma e alergia em Angola
-
Paediatric multisystem allergy: a new diagnostic and severity score
-
Diagnosis of insect venom allergy: back to basics
-
Implementing component resolved diagnostics in allergy diagnosis
-
Diagnosis of NSAIDs-Exacerbated respiratory disease (N-ERD)
-
Living with food allergy
-
Exercise: induced asthma and rhinitis
-
Therapies for multiple-tree nut allergies
-
Role Viral reactivations
-
When to suspect allergic contact dermatitis in atopic dermatitis patients
-
Understanding parent preferences for paediatric allergy services
-
Predicting adverse reactions to biologicals
-
Eosinophil ETosis, a cytolytic degranulation and diseases
-
AI models
-
Cow’s milk protein-induced allergic proctocolitis: cohort review
-
An update on food allergy
-
Hypersensitivity to antiepileptic drugs
-
Prevention of food allergy: where are we now?
-
Do adrenaline auto-injectors save lives?
-
Late onset T2 asthma – a case study
-
Novel pharamacological targets
-
Basophil activation tests and allergy to COVID-19 vaccines
-
Microbiota in immune-based therapies
-
Entre US y Europa. La Experiencia de la Inmunoterapia en Mexico
-
Recognizing immediate reactions in contact dermatitis
-
Telemedicine and Tele-health
-
Launch of the Biological guidelines
-
AIT in the pediatric population
-
Potential biomarkers for diagnosis and treatment for CSU
-
Current and future perspectives
-
New and clinically relevant contact allergens
-
Treating allergic patients during the COVID-19 pandemic
-
Immunological basis of food aversion
-
It looks like urticaria – but is it?
-
Hologenome and obesity
-
Big Data Analysis: MetabolomicsView Presentation
-
Exercise-induced urticaria and anaphylaxis
-
Collective advocacy for action on CRDs
-
When is it not a food allergy? Dietary approaches to the diagnosis of histamine intolerance
-
The engineering-medicine interface
-
Should we use partial allergen sequence information for food allergy risk assessment?
-
Evidence of immunotherapy on allergy prevention?
-
Precision Medicine and AIT
-
Early biomarkers for severe drug hypersensitivity reactions
-
Elevated tryptase – Now what?
-
Alternative free-from foods to reach a balanced diet
-
Hand eczema during the COVID-19 pandemic
-
Tackling anaphylaxis
-
Developing an adolescent and young adult allergy service
-
Challenges on the implementation of early introduction of allergenic foods
Show more Event Resources (78)Show Less-
Website
Collapse